Leo Redmond

Leo Redmond is chief financial officer of Aulos and brings to the company nearly three decades of financial experience in the biopharmaceutical industry. Prior to joining Aulos, he was chief financial officer for Allakos, a publicly-held antibody therapeutics company. Previously, he served for 11 years as president, chief financial officer and secretary of Presidio Pharmaceuticals. Mr. Redmond also spent nearly 16 years at Genentech, where he held senior leadership positions, including senior director of finance, and served as chief financial officer and secretary for the Foundation of Biomedical Sciences. Earlier in his career, he held various financial roles at the GTE Corporation. Mr. Redmond has served as a member of Presidio Pharmaceuticals’ board of directors since 2011.

Mr. Redmond earned a B.S. in Accounting and Business Administration from the University of Kansas and an MBA from the UCLA Anderson School of Management.